| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $884K | +141.9% | +69.3% |
| Cost of Revenue | $757K | +217.5% | +69.0% |
| Gross Profit | $127K | +24.3% | +70.9% |
| R&D Expense | $1.3M | +28.6% | +43.2% |
| SG&A Expense | $2.7M | -43.4% | +96.2% |
| Operating Income | -$3.9M | +31.3% | -75.0% |
| Pre-tax Income | -$6.9M | -158.2% | -21.6% |
| Net Income | -$6.9M | -158.2% | -21.6% |
| EPS (Basic) | -$0.16 | -33.3% | +91.0% |
| EPS (Diluted) | -$0.16 | -33.3% | +91.0% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $287K | — | — |
| Inventory | $1.8M | +38.1% | — |
| Current Assets | $4.5M | -12.9% | — |
| Total Assets | $4.6M | -12.7% | — |
| Current Liabilities | $27.4M | -37.1% | — |
| Long-term Debt | $17.7M | +0.0% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | +1.9% | — |
| Capital Expenditures | $16K | +129.6% | — |
| Investing Cash Flow | -$16K | -129.6% | — |
| Financing Cash Flow | $3.6M | -17.9% | — |
| Free Cash Flow | -$3.6M | +1.7% | — |
| Total Liabilities | $45.1M | -26.4% | — |
| Stockholders' Equity | -$40.5M | +27.7% | +78.1% |